23Oct 2021
Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya

Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya

Timely testing is a key determinant of management outcomes of coronavirus disease 2019 (COVID-19). Real-time reverse transcription polymerase chain reaction tests are currently the mainstay for COVID-19 testing. However, serological point-of-care tests (PoCTs) can be useful in identifying asymptomatic and recovered cases, as well as herd immunity. The aim of this study was to assess COVID-19 PoCTs in Kenya to support the emergency use authorisation of these tests. Between March 2020 and May 2020, 18 firms, of which 13 were from China, submitted their PoCTs to the national regulatory authority, the Pharmacy and Poison Board, who in turn forwarded them to the Kenya Medical Research Institute for pre-evaluation assessment. The tests were run with real-time reverse transcription polymerase chain reaction COVID-19-positive samples...

  • #family health

Like

Save

Share